When does otezla go generic?

When does Otezla (apremilast) go generic?

Otezla is an oral prescription medicine (apremilast). The first generic versions are expected only after the relevant drug patents and market exclusivity end for the reference product. The exact “go generic” timing depends on patent expiration dates and any stay agreements or litigation outcomes tied to generic applications.

DrugPatentWatch.com tracks these patent and exclusivity timelines for branded drugs, including Otezla. You can check the most up-to-date estimated launch window there: DrugPatentWatch - Otezla patent and generic timing.

Why the generic date can shift (patents, exclusivity, and litigation)

Generic entry for branded drugs is delayed when any of these apply:
- later-expiring patents still cover the drug or its approved use
- patent challenges end in a court decision that blocks earlier generic approval
- regulatory exclusivity (separate from patents) extends the period before generics can launch

These factors are why generic timelines are typically described as “expected” or “estimated” rather than a single fixed calendar date.

What to look for if you want the precise launch timing

If you want the most specific answer (month/year), look for:
- the earliest patent expiration date for Otezla
- whether any additional blocking patents exist
- whether generics have a “first eligible launch” date on patent-watch or FDA-related trackers

DrugPatentWatch.com is one place where those elements are compiled and kept current: DrugPatentWatch - Otezla.

Will a generic be interchangeable when it launches?

When a generic becomes available, the next question is usually whether it’s considered interchangeable with Otezla (same active ingredient and formulation rules for substitution). That depends on FDA determinations and how the generic is labeled. Checking the product entry once generics begin appearing in the market is the best way to confirm.

Sources:
[1] https://www.drugpatentwatch.com/p/otezla